Intrastromal voriconazole for deep recalcitrant fungal keratitis: A case series

British Journal of Ophthalmology

Volumn 99, Issue 2, 2015, Pages 195-198

  Kalaiselvi, Ganapathy ^a   Narayana, Sivananda ^a   Krishnan, Tiruvengada ^a   Sengupta, Sabyasachi ^a  

^a ARAVIND EYE HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

NATAMYCIN; VORICONAZOLE; ANTIFUNGAL AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FUNGUS CULTURE; FUSARIOSIS; HUMAN; HYPOPYON; INTRASTROMAL DRUG ADMINISTRATION; KERATOMYCOSIS; MALE; OUTCOME ASSESSMENT; TREATMENT RESPONSE; CORNEA STROMA; CORNEAL ULCER; DRUG EFFECTS; EYE INFECTIONS, FUNGAL; FOLLOW UP; FUNGUS; INTRAOCULAR DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY; TREATMENT OUTCOME; VERY ELDERLY; VISUAL ACUITY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CORNEAL STROMA; CORNEAL ULCER; EYE INFECTIONS, FUNGAL; FEMALE; FOLLOW-UP STUDIES; FUNGI; HUMANS; INJECTIONS, INTRAOCULAR; MALE; MIDDLE AGED; TREATMENT OUTCOME; VISUAL ACUITY; VORICONAZOLE; YOUNG ADULT;

EID: 84921490573     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2014-305412     Document Type: Article

References (25)

1. Sengupta S, Krishnan T, Ravindran RD, et al. Changing referral patterns of infectious corneal ulcers to a tertiary care facility in South India - 7-year analysis. Ophthalmic Epidemiol 2012;19:297-301.
2. O'Day D, Head W, Robinson R, et al. Corneal penetration of topical amphotericin B and natamycin. Curr Eye Res 1986;5:877-82.
3. Kaur IP, Rana C, Singh H. Development of effective ocular preparations of antifungal agents. J Ocul Pharmacol Ther 2008;24:481-93.
4. Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol 2004;15:321-7.
5. Diekema DJ, Messer SA, Hollis RJ, et al. Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol 2003;41:3623-6.
6. Hariprasad SM, Mieler WF, Lin TK, et al. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol 2008;92:871-8.
7. Kernt M, Kampik A. Intracameral Voriconazole: in vitro safety for human ocular cells. Toxicology 2009;258:84-93.
8. Panda A, Vajpayee RB, Kumar TS. Critical evaluation of therapeutic keratoplasty in cases of keratomycosis. Ann Ophthalmol 1991;23:373-6.
9. Isipradit S. Efficacy of fluconazole subconjunctival injection as adjunctive therapy for severe recalcitrant fungal corneal ulcer. J Med Assoc Thai 2008;91:309-15.
10. Kaushik S, Ram J, Brar GS, et al. Intracameral amphotericin B: initial experience in severe keratomycosis. Cornea 2001;20:715-19.
11. Kuriakose T, Kothari M, Paul P, et al. Intracameral amphotericin B injection in the management of deep keratomycosis. Cornea 2002;21:653-6.
12. Garcia-Valenzuela E, Song CD. Intracorneal injection of amphotericin B for recurrent fungal keratitis and endophthalmitis. Arch Ophthalmol 2005;123:1721-3.
13. Prakash G, Sharma N, Goel M, et al. Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis. Am J Ophthalmol 2008;146:56-9.
14. Sharma N, Agarwal P, Sinha R, et al. Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: Case series. Br J Ophthalmol 2011;95:1735-7.
15. Siatiri H, Daneshgar F, Siatiri N, et al. The effects of intrastromal voriconazole injection and topical voriconazole in the treatment of recalcitrant Fusarium keratitis. Cornea 2011;30:872-5.
16. Tu EY. Alternaria keratitis: clinical presentation and resolution with topical fluconazole or intrastromal voriconazole and topical caspofungin. Cornea 2009;28:116-19.
17. Neoh CF, Leung L, Vajpayee RB, et al. Treatment of Alternaria Keratitis with Intrastromal and Topical Caspofungin in combination with Intrastromal, Topical, and Oral Voriconazole. Ann Pharmacother 2011;45:e24.
18. Jain V, Borse N, Shome D, et al. Recalcitrant fungal tunnel infection treated with intrastromal injection of voriconazole. Int Ophthalmol 2010;30:723-5.
19. Sengupta S, Rajan S, Krishnan T, et al. Comparative study on the incidence and outcomes of pigmented versus non pigmented keratomycosis. Indian J Ophthalmol 2011;59:291-6.
20. Al-Badriyeh D, Neoh CF, Stewart K, et al. Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis. Clin Ophthalmol 2010;4:391-405.
21. Sponel W, Chen N, Dang D, et al. Topical voriconazole as a novel treatment for fungal keratitis. Antimicrob Agents Chemother 2006;50:262-8.
22. Lalitha P, Prajna NV, Kabra A, et al. Risk factor for treatment outcome in fungal keratitis. Ophthalmology 2006;113:526-30.
23. Alastruey-Izquierdo A, Cuenca-Estrella M, Monzón A, et al. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J Antimicrob Chemother 2008;61:805-9.
24. Prajna NV, Krishnan T, Mascarenhas J, et al. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol 2013;131:422-9.
25. Sharma N, Chacko J, Velpandian T, et al. Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis. Ophthalmology 2013;120:677-81.